Trials / Completed
CompletedNCT04278079
Vitrectomy With Internal Limiting Membrane Peeling for Myopic Traction Maculopathy
Evaluation of Pars Plana Vitrectomy With Internal Limiting Membrane Peeling for Myopic Traction Maculopathy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- Tanta University · Academic / Other
- Sex
- All
- Age
- 30 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Investigate the effectiveness and safety of pars plans vitrectomy, with internal limiting membrane peeling for cases of myopic traction maculopathy
Detailed description
Performing pars plana vitrectomy for highly myopic patients with decreased visual acuity is the standard of care for patients with myopic traction. A variety of findings are seen by Optical Coherence Tomography. Epiretinal membranes, retinoschisis, lamellar macular holes, and full thickness macular holes are seen. Undergoing vitrectomy, with or without tamponade, in our center, is retrospectively evaluated. Visual acuity change, as well as improvement of the retinal structure by OCT will be examined.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Pars Plana Vitrectomy with Internal Limiting Membrane peel | Pars plana vitrectomy with staining and peeling of internal limiting membrane |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2019-12-01
- Completion
- 2020-02-01
- First posted
- 2020-02-20
- Last updated
- 2020-02-20
Source: ClinicalTrials.gov record NCT04278079. Inclusion in this directory is not an endorsement.